CELL INTELLIGENCE · 肿瘤细胞治疗研究

基因调控元件决定 BCMA 靶向 CAR-T 细胞产品的疗效

Gene regulatory elements determine efficacy of BCMA-targeted CAR-T cell products.

用于儿童实体瘤的 CAR-T 细胞疗法：装甲 CAR-T 细胞及其他

CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond.

通过 IL-8 引导 B7-H3 CAR-T 细胞归巢诱导对儿童肉瘤的强效抗肿瘤活性

Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma.

这些发现值得进一步研究 BC2 CAR-T 细胞用于治疗 RMS、OS 及其他表达 B7-H3、产生 IL-8 的实体瘤患者。

CAR-T 治疗的疗效、安全性和成本效果

Efficacy, safety and cost-effectiveness of CAR-T therapy.

CAR-T 细胞治疗背景下的多发性骨髓瘤向髓系肉瘤转分化

Transdifferentiation From Multiple Myeloma to Myeloid Sarcoma in the Setting of CAR T-Cell Therapy.

靶向 CD70 的 CAR-T/NK 治疗：原理、进展和未来方向

CD70-targeted CAR-T/NK therapy: Rationale, advances, and future directions.

过继性细胞疗法治疗肉瘤的综述

Review of Adoptive Cellular Therapies for the Treatment of Sarcoma.